+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Internal medicine diseases and anti-thrombotic therapy. Angiitis and thrombotic microangiopathy - mainly for the kidney



Internal medicine diseases and anti-thrombotic therapy. Angiitis and thrombotic microangiopathy - mainly for the kidney



Nihon Naika Gakkai Zasshi 86(9): 1634-1638




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062624099

Download citation: RISBibTeXText

DOI: 10.2169/naika.86.1634


Related references

Internal medicine diseases and anti-thrombotic therapy. Anti-thrombotic therapy for arteriosclerotic diseases. Symptomatic/asymptomatic cerebral infarction. Nihon Naika Gakkai Zasshi 86(9): 1617-1620, 1997

Internal medicine diseases and anti-thrombotic therapy. Anti-thrombotic therapy for arteriosclerotic diseases. Ischemic heart diseases ( antiplatelet therapy ). Nihon Naika Gakkai Zasshi 86(9): 1621-1624, 1997

Internal medicine diseases and anti-thrombotic therapy. Anti-thrombotic therapy for arteriosclerotic diseases. Ischemic heart diseases ( thrombolytic therapy ). Nihon Naika Gakkai Zasshi 86(9): 1625-1628, 1997

Internal medicine diseases and anti-thrombotic therapy. Nephrotic syndrome and anti-thrombotic therapy. Nihon Naika Gakkai Zasshi 86(9): 1639-1643, 1997

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet. Haematology 3(5): E237-E245, 2016

Internal medicine diseases and anti-thrombotic therapy. Multiple thromboembolism - atrial fibrillation. Nihon Naika Gakkai Zasshi 86(9): 1629-1633, 1997

Is it possible to diagnose primary anti-phospholipid syndrome on the basis of renal thrombotic microangiopathy in the absence of other thrombotic process?. Renal Failure 25(6): 1043-1049, 2003

Is It Possible to Diagnose Primary Anti-phospholipid Syndrome (Paps) on the Basis of Renal Thrombotic Microangiopathy (Paps Nephropathy) in the Absence of Other Thrombotic Process?. Renal Failure 25(6): 1043-1049, 2003

Anti-neutrophil cytoplasmic autoantibodies associated renal diseases and thrombotic microangiopathy. Internal Medicine 37(2): 207-210, 1998

Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group. Mayo Clinic Proceedings 91(9): 1189-1211, 2016

De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. American Journal of Kidney Diseases 41(2): 471-479, 2003

Thrombolytic therapy of vasculitis and thrombotic microangiopathy--with special reference to the kidney. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 86(9): 1634-1638, 1997

Biology of anti-angiogenic therapy-induced thrombotic microangiopathy. Seminars in Nephrology 30(6): 582-590, 2010

Anti-vascular endothelial growth factor therapy and renal thrombotic microangiopathy. Archives of Ophthalmology 129(8): 1082, 2011

Dental treatment and anti-thrombotic therapy. Part II: the era of new anti-thrombotic drugs. Refu'at Ha-Peh Veha-Shinayim 31(1): 43-9 63, 2014